Pathology & Oncology Research
Theme:- Innovations in Pathology and Research in Oncology.
EuroSciCon extends its warm welcome to all its participants to Pathology & Oncology 2020 scheduled on December 14-15, 2020 with a theme “Innovations in Pathology and Research in Oncology". EuroSciCon organizes Global Events with Conferences, Symposiums and Workshops on Medical, Parma, Engineering, Science, Technology and Business.
We gladly welcome attendees all around the world for the hearing of the foremost recent innovations and inventions in the field of Pathology & Oncology. This Conference will provide a forum for exchange of ideas and authoritative views by leading scientists, industry specialists and also from the academicians of the best institutes from around the globe. Outstanding keynote speakers and well known leading scientists and experts from around the globe will be expected to share their knowledge and talk about various aspects related to various frontiers in the field of Oncology . Our aspiration is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the knowledge that’s still more to be revealed. Gain and grab the knowledge. Conferences and symposia provide unlimited opportunities to strengthen the community, and are also the collective body of knowledge. We cordially encourage you to attend and contribute to one of the major events of 2020 on the field of Oncology& Pathology. The conference will reveal the present and future aspects in the field of Oncology which are the need of the hour for instant and précised treatment.
Oncology & Pathology:
The branch of health care determines safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed Clinical Research These are used for the treatment purpose, prevention, diagnosis and relieving symptoms of the diseases. Clinical research varies from clinical practice. Clinical practice uses established, whereas in case of clinical research evidence is collected for establishing the new treatment. And “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.
Who and Why??
Oncology & Pathology Conference brings together the specialists from all the aspects to meet and discuss the future of Oncology & Pathology in today’s world to thrive and survive with a better health. The conference will bring together Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, CRO’s, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies, Medical device specialist and all the interested participants willing to enhance and update the knowledge on Oncology . tors, Doctors, Director of Laboratories, Universities, Industries, Delegates, Oncology Research
SESSIONS AND TRACKS
Track -1. Pathology
Pathology is the study of the essential nature of diseases, especially of the structural and functional changes in body tissues and organs that cause or are caused by disease due to deviation from propriety. Pathology precisely refers to the study of the origin, nature, and course of diseases. Pathology deals with the laboratory examination of samples of body tissue for diagnostic or forensic purposes.
Track- 2. Histologic Pathology
Histologic Pathology alludes to the minute examination of tissue keeping in mind the end goal to concentrate on the signs of sickness. In particular, in clinical solution, histopathology alludes to the examination of a biopsy or surgical example by a pathologist, after the example has been handled and histological segments have been set onto glass slides. Conversely, cytopathology looks at free cells or tissue sections.
Track-3: Oncology Pathology
Tumour is a gathering of infections including unusual cell development with the possibility to spread to different parts of the body .It can be either benign or malignant cancer that possesses no physiological function and arises from uncontrolled usually rapid cellular proliferation. Not all tumors are harmful; kind hearted tumors don't spread to different parts of the body. Conceivable signs and indications incorporate a protuberance, strange dying, delayed hack, unexplained weight reduction and an adjustment in defecations. While these side effects may demonstrate tumor and it may have different causes, there are more than 100 cancers that affect humans. The pathology related to tumors is known as cancer pathology. It is the task of the surgical pathologist to provide an accurate, specific, and sufficiently comprehensive diagnosis to enable the clinician to develop an optimal plan of treatment and, to the extent possible, estimate prognosis of cancer through pathological report.
Track-4: Breast Pathology
Breast Pathology can help in knowing the stage of a cancer and the grading of cancer that is a measurement of the extent of the tumor and its spread.Breast infections can be classified either with disorders of the integument, or disarranges of the regenerative framework. A greater part of breast sicknesses are noncancerous which can be confirmed with pathology report. A breast neoplasm might be favourable, as in fibro adenoma, or it might be harmful, in which case it is named breast carcinoma after pathological testing of biopsy. In either case it shows a lump in the breast which could be painful in few. Around 7% of breast bumps are fibro adenomas and 10% are breast malignancy, the rest being conditions of no disease.A tumor mass can be non-cancerous and can be due to something like swelling or inflammation.
Neuromuscular pathology is the study of muscle and neurologic disease associated with muscle dysfunction. It is a part of neuropathology Muscle pathology is dealt together with neurologic disease. Neuromuscular pathology disorders commonly have impaired motor activity, i.e. slowed or obstructed transit with radiological evidence of transient or persistent visceral dilatation. Neuromuscular diseases include a wide-ranging variety of pathologies that can produce significant disability for the patient. It differs from neuropathology because it is highly integrated with the clinical management of neuromuscular disease.
Track -6:Hematopathology & Oncology
Hematopathology or hemopathology is the branch of pathology which studies diseases of hematopoietic cells. Blood malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukaemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Hematopathology deals in differentiation and diagnosing Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes.
7. Cytopathology & Ophthalmic Pathology
Cytopathology is the examination of cells extracted from tissues of the body under the microscope to determine the signs and characteristics of disease. Cytopathology is often called "cytology," a branch of pathology that deals with manifestations of disease at the cellular level.A cytopathology report tells us whether the cells studied contain signs of a disease. Cells examined for cytopathology can come from fluids extracted from body cavities - e.g. urine, sputum or fluids accumulating inside the chest or abdomen. Cells can also be extracted by inserting needles into lumps or diseased areas or tissues which is called fine needle aspiration cytology (FNAC).
Track-8: Radiation Oncology
Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiotherapy/radiation therapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Nuclear medicine is a branch of medicine that uses radiation to provide information about the functioning of a person's specific organs or to treat disease. Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.
Track-9:Cancer Vaccines and Therapeutics
Cancer Vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.
Track-10: Trends in Oncology
Trends in Cancer provide current updates, opinions, and discussions on an exhilarating current Oncoclogy research. Every issue of Trends in Cancer will be on the list of latest trends, important developments, and new ideas both within and outside their specialist area. A vaccine for cancer will either helps in preventing the development of a cancer or treats existing cancer. Vaccines that help in treating existing cancer are known to be therapeutic cancer vaccines. A major barrier to converting cancer therapies into curing is drug resistance in a very short span. Cancer cells often develop resistance to even the most effective therapeutic plans. Immunology in Cancer is a branch of biology that is concerned with understanding the correlation between the immune system and progression, development of cancer; Cancer immunology utilizes the immune system as a treatment for cancer.
Cancer epidemiology is the investigation of the variables influencing growth, as an approach to interpret conceivable patterns and causes. The investigation of growth the study of sickness transmission utilizes epidemiologic methods to get the explanation for tumor and to diagonize and build enhanced medicines. This region of study must fight with problems with lead time inclination and length time predisposition. A related concern is over identification, the propensity of screening tests to analyse illness that may not extremely have an effect on the patient's life.